Assessing Patterns of Continuous Glucose Monitoring Use and Metrics of Glycemic Control in Type 1 Diabetes and Type 2 Diabetes Patients in the Veterans Health Care System: Integrating Continuous Glucose Monitoring Device Data with Electronic Health Records Data
- 8 November 2024
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 26 (11) , 806-813
Abstract
Objective: To integrate long-term daily continuous glucose monitoring (CGM) device data with electronic health records (EHR) for patients with type 1 and type 2 diabetes (T1D and T2D) in the national Veterans Affairs Healthcare System to assess real-world patterns of CGM use and the reliability of EHR-based CGM information. Research Design and Methods: This observational study used Dexcom CGM device data linked with EHR (from 2015 to 2020) for a large national cohort of patients with diabetes. We tracked the initiation and consistency of CGM use, assessed concordance of CGM use and measures of glucose control between CGM device data and EHR records, and examined results by age, ethnicity, and diabetes type. Results: The time from pharmacy release of CGM to patients to initiation of uploading CGM data to Dexcom servers averaged 3 weeks but demonstrated wide variation among individuals; importantly, this delay decreased markedly over the later years. The average daily wear time of CGM exceeded 22 h over nearly 3 years of follow-up. Patterns of CGM use were generally consistent across age, race/ethnicity groups, and diabetes type. There was strong concordance between EHR-based estimates of CGM use and Dexcom CGM wear time and between estimates of glucose control from both sources. Conclusions: The study demonstrates our ability to reliably integrate CGM devices and EHR data to provide valuable insights into CGM use patterns. The results indicate in the real-world environment that CGM is worn consistently over many years for both patients with T1D and T2D within the Veterans Affairs Healthcare System and is similar across major race/ethnic groups and age-groups.Keywords
This publication has 21 references indexed in Scilit:
- Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysisDiabetologia, 2022
- Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated DiabetesJAMA, 2021
- Racial–Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 DiabetesDiabetes Technology & Therapeutics, 2021
- Type 2 Diabetes and the Use of Real-Time Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2021
- Benefits and Challenges of Diabetes Technology Use in Older AdultsEndocrinology and Metabolism Clinics of North America, 2020
- Impact of mismatches in HbA1c vs glucose values on the diagnostic classification of diabetes and prediabetesDiabetic Medicine, 2019
- The Relationship of Hemoglobin A1C to Time-in-Range in Patients with DiabetesDiabetes Technology & Therapeutics, 2019
- The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1cJournal of Diabetes Science and Technology, 2019
- The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysisDiabetes Technology & Therapeutics, 2018
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008